Low-dose isotretinoin may be effective, with fewer side effects, when used to treat adult acne, results of a clinical trial presented at the annual congress of the European Academy of Dermatology and Venereology suggest.
Interview Intersection: Expert Interviews From September 2024
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
The Weekly Roundup: September 23-27
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
LEO Pharma Presents Extensive Data at EADV
Melinda Gooderham, MSc, MD, FRCPC: Insights Into Lebrikizumab’s Sustained 3-Year Efficacy